Web Results

www.medpagetoday.com/painmanagement/painmanagement/47855

Sep 29, 2014 ... Although he has admitted to minimizing the risks of opioid analgesics, Russell Portenoy, MD, is still sought out as a key opinion leader on these drugs -- and his latest speaking engagement is at a 2-day National Institutes of Health workshop on opioids that begins Monday. Sources within NIH have ...

www.practicalpainmanagement.com/author/16278/portenoy

Russell K. Portenoy, MD Executive Director, MJHS Institute for Innovation in Palliative Care Chief Medical Officer, MJHS Hospice and Palliative Care Dr. Russell Portenoy is Director of the MJHS Institute for Innovation in Palliative Care and Chief Medical Officer of MJHS Hospice and Palliative Care. He is also a Professor of ...

www.health.com/health/condition-article/0,,20189630,00.html

Mar 17, 2016 ... "Only about 5% of people with chronic pain ever see a specialist."(RUSSELL K. PORTENOY). Russell K. Portenoy, MD, is chairman of the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center in New York City. Q: Would you say that opioids are a last resort? A: No. Opioids should ...

www.minnpost.com/second-opinion/2012/12/doctor-who-encouraged-wider-use-opioid-painkillers-having-second-thoughts

Dec 18, 2012 ... Dr. Russell Portenoy, the New York-based pain-care specialist who helped lead the campaign in the 1990s to make prescription pain medications more widely available, is apparently having second thoughts about the wisdom of that effort.

www.wsj.com/articles/SB10001424127887324478304578173342657044604

Dec 17, 2012 ... Russell Portenoy, a longtime champion of the use of opioid medications to treat chronic pain, today says experts overemphasized the benefits and glossed over the risks.

www.ncbi.nlm.nih.gov/pubmed/2873550

Portenoy RK, Foley KM. Thirty-eight patients maintained on opioid analgesics for non-malignant pain were retrospectively evaluated to determine the indications, course, safety and efficacy of this therapy. Oxycodone was used by 12 patients, methadone by 7, and levorphanol by 5; others were treated with propoxyphene, ...

www.thepoisonreview.com/2012/12/16/the-money-and-influence-behind-pain-as-a-fifth-vital-sign

Dec 16, 2012 ... A must-read article in the Wall Street Journal this weekend focuses on Dr. Russell Portenoy, a New York City pain specialist who two decades ago was instrumental in the drive to expand use of opioid analgesics to treat chronic pain. (Unfortunately, the article is behind the WSJ firewall and requires ...

www.cnn.com/2016/05/12/health/opioid-addiction-history/index.html

Oct 14, 2016 ... Patients with terminal illnesses started being treated more with prescription opioids, and doctors and researchers wanted to look at treating patients with chronic pain. Six years later, a paper by pain-management specialist Dr. Russell Portenoy chronicled 38 patients treated with opioids for non-cancer pain.

www.statnews.com/2017/03/24/pain-documentary-public-television

Mar 24, 2017 ... Among the physicians featured in the documentary is Dr. Russell Portenoy 21, who helped write a 1996 consensus statement on behalf of two pain societies that has been criticized for allegedly playing down the risk of addiction and overdose with opioids when prescribed to treat chronic pain. Portenoy ...